Breaking News

Tweet TWEET

EntreMed, Boston Life Sciences, Vical Among 40-Plus

                     Public/Private Companies Streamed Live March 28 by InformedInvestors.com at Boston BIO 2000 Conference  BOSTON, March 27 /PRNewswire/ -- Nearly 50 companies, both publicly- and privately-held, will be presenting on the second day of the huge International Investors & Partnering Forum at the Biotechnology Industry Organization's (BIO) annual conference and exhibition March 28 in Boston.  Among the public companies scheduled to present Tuesday include local companies Boston Life Sciences (Nasdaq: BLSI) and private company Genzyme Corp plus its publicly-traded affiliates Genzyme Transgenics (Nasdaq: GZTC) and Genzyme Molecular Oncology (Nasdaq: GZMO). Other high-profile presenting companies are EntreMed (Nasdaq: ENMD) and Vical (Nasdaq: VICL).  To tune in free and live beginning at 8 a.m. EST, and for the full schedule, visit www.informedinvestors.com and click on "Listen to BIO 2000." Executive presentations for the complete International Investors and Partnering Forum component of the BIO conference will also be archived for replay. In addition, audio tapes are available.  "Live streaming of both public and private companies gives biotech investors anywhere in the world true and deep insight into the direction and drivers of the biotechnology industry," said Tim Quast, InformedInvestors.com President and COO. "We are delighted to work with BIO to bring these fascinating presentations to investors."  EntreMed is among the most visible companies in biotechnology. The Rockville, Md.-based company bills itself as "The Angiogenesis Company(TM)" and is a leader in the field of antiangiogenesis research, which involves the inhibition of abnormal blood vessel growth associated with a broad range of diseases. EntreMed's science applied to cancer treatments has received substantial publicity and generated wide investor interest.  Other public companies scheduled Tuesday include ArQule (Nasdaq: ARQL), Trega Biosciences (Nasdaq: TRGA) and Creative BioMolecules (Nasdaq: CBMI). Nearly 40 private companies are also scheduled to present their business prospects and scientific progress. Companies present in two simultaneous tracks.  The Biotechnology Industry Organization (BIO) represents biotechnology companies, academic institutions, state biotechnology centers and related organizations throughout the United States and in many other countries. The members of BIO apply biological knowledge and techniques to develop products and services for use in health care, agriculture, environmental remediation, and other fields. See details at www.bio.org.  InformedInvestors.com is the leading producer of online and offline industry-specific investment conferences for individual investors and offers a growing stable of resources for in-depth sector-analysis, including the weekly biotech-sector radio show, "BioTalk."    SOURCE  InformedInvestors.com /CONTACT:  Steve Chanecka of InformedInvestors.com, 916-780-6100, or 800-992-4683/        /Web site:  http://www.bio.org/     /Web site:  http://www.informedinvestors.com/     (BLSI GZTC GZMO ENMD VICL ARQL TRGA CBMI)  CO:  InformedInvestors.com; Boston Life Sciences; Genzyme Corp.; Genzyme      Transgenics; Genzyme Molecular Oncology; EntreMed; Vical; ArQule; Trega    Biosciences; Creative BioMolecules; Biotechnology Industry Organization ST:  California, Massachusetts, Maryland IN:  MTC BIO MLM SU:  TDS 
Press spacebar to pause and continue. Press esc to stop.